Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol RARRES3 contributors: mct - updated : 18-05-2010
HGNC name retinoic acid receptor responder (tazarotene induced) 3
HGNC id 9869
Location 11q12.3      Physical location : 63.304.272 - 63.313.929
Synonym name
  • retinoic acid inducible 1
  • tazarotene-induced gene 3
  • RAR-responsive protein TIG3
  • Synonym symbol(s) TIG3, RIG1, HRASLS4, MGC8906, RIG-1, PLA1/2-3
    DNA
    TYPE functioning gene
    STRUCTURE 9.66 kb     4 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    4 - 779 18 164 - 2009 19615464
    EXPRESSION
    Type widely
    constitutive of
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Digestivestomach   highly
    Respiratorylung    
    Urinarybladder   highly
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • N-terminal region containing the CARD domain, conjugated to ubiquitin, and is required for RARRES3-dependent keratinocyte differentiation
  • minimal incorporation of ubiquitin to the C-terminal half, hydrophobic domain, two caspase activation and recruitment domains (CARDs)
  • three myristoylation sites
  • C-terminal helicase domain, membrane-anchoring domain
  • HOMOLOGY
    intraspecies homolog to REV107-1 tumor supressor
    Homologene
    FAMILY
  • lecithin retinol acyltransferase (LRAT) protein family
  • H-rev107 family
  • CATEGORY receptor nuclear
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,cytosolic
    basic FUNCTION
  • may function as an antiproliferative and antitumor agent
  • playing a pivotal role in the regulation of cytokine production induced by pathogens
  • implicated in innate immunity by sensing intracellular viral RNAs and inducing type I IFN production
  • critical regulatory role in modulating the generation and differentiation of granulocytes
  • initiates a signaling cascade that activates innate immune response by interferon and cytokine production, providing essential antiviral protection for the host
  • cytosolic receptor that recognizes viral RNA and activates the interferon-mediated innate antiviral response
  • playing a critical regulatory role in modulating the generation and differentiation of granulocytes (negatively regulating granulocytic proliferation)
  • with HRASLS2 and PLA2G16, are involved in the phospholipid metabolism with different physiological roles
  • important viral RNA recognition molecule, associated with the actin cytoskeleton and localized predominantly to actin-enriched membrane ruffles in non-polarized epithelial cells
  • physiological role in the regulation of cellular migration
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacting with CYLD (negative regulator of RARRES3-mediated innate antiviral response)
  • caspase-1 physically interacted with full length RARRES3 (enzymatic activity of caspase-1 was necessary to control RARRES3, although it was not a substrate of proteolytic cleavage by caspase-1)
  • interaction with TGM1 does not require the N-terminal conserved domain
  • cell & other
    REGULATION
    activated by retinoic acid through the heterodimer of retinoic acid receptor and retinoic X receptor
    induced by by retinoic acid in head and neck and lung carcinoma cells
    tazarotene
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --low  
    leads to the development of a progressive myeloproliferative disorder
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS